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ABSTRACT

SPINAL CORD INJURY: EXPLORING THE HISTOLOGY OF ELECTROSPUN
IMPLANTS IN VIVO
Charles Shin Lin, Master of Science
A thesis in partial fulfillment of the requirements for the degree of Master of Science in
Anatomy at Virginia Commonwealth University.
Virginia Commonwealth University, 2010
Raymond J. Colello, D.Phil., Associate Professor, Department of Anatomy and
Neurobiology

Spinal cord injury results in loss of motor function and sensory perception. A
myriad of obstacles prevent axonal regeneration and ultimately functional recovery in
those afflicted with spinal cord injury. Combinatorial strategies addressing many of
these obstacles simultaneously have shown promising results. Laboratories
investigating contusional spinal cord injuries must overcome the formation of a fluid
filled cyst, a physical gap that axons must traverse, at the injury epicenter. To fill the
cyst, our lab has generated a 3-D electrospun matrix that is capable of directing neurite
outgrowth, delivering neurotrophic support, and reducing the activity of neuroinhibitory
compounds. These electrospun matrices were surgically implanted into female Long
Evans Hooded rats aged approximately 60 days using a complete transection model of
SCI. Following injury, rats with implants showed greater functional recovery than
controls. In Chapter 1, we introduce spinal cord injury, the epidemiology, pathology
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and potential for regeneration, followed by our novel electrospun implant. Chapter 2
details the materials and methods. In Chapter 3, we relate the functional recovery seen
to a histological analysis. The histological analysis consists of three parts: the implant
integration into the host, the axons above, in and below the implant, and the functional
vascular supply found within the implant. In Chapter 4, we designed a modified
implant and discuss the use of this implant in vivo. With our modified implant we were
able to demonstrate cellular influx and the generation of a vascular network within the
implant, but poor axonal regeneration. Finally in chapter 5, I discuss potential future
modifications to our electrospun matrix as well as suggestions to consider for improved
functional outcome.

Chapter 1
Spinal Cord Injury Anatomy, Pathology, and a combinatorial
therapeutic effort

Synopsis:
What is Spinal Cord Injury?
Injury to the spinal cord results in tissue necrosis and axon severing, disrupting
communication pathways between the brain and peripheral targets. The result is often a
loss of sensation and movement in the affected region. The spinal cord injury (SCI)
consists of initial as well as secondary events. Following initial trauma causing tissue
loss, secondary injury often further damages the cord and restricts the potential for
regeneration. Inflammatory cells infiltrate the injured area and release substrates which
drives neurons and glia into apoptosis. The massive cell death from primary and
secondary injury results in cell and myelin debris, which inhibit axon growth.
Furthermore, glial cells at the border of the injury activate, proliferate and hypertrophy
in reaction to the primary insult. The result is a scar-like barrier and the expression of
various axon growth inhibitory compounds. The end result of these secondary events is
often a fluid filled cyst, which acts as a physical barrier that further complicates the
potential for regeneration. These cellular and biochemical events mentioned are only
some of many problems in the struggle to understand and treat spinal cord injuries. The
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complexity of the injury makes it understandable that no singular approach to spinal
cord injury has had success in the past. Combinatorial strategies and therapies that
target multiple obstacles offer new hope for the future. This dissertation examines
histology behind the implantation of a 3D electrospun matrix that targets multiple
therapeutic obstacles in a complete transection model of spinal cord injury in rats. First,
we discuss spinal cord anatomy, pathology, epidemiology, and blood supply. Then we
introduce many obstacles that prevent regeneration in the damaged spinal cord, and the
therapies that have been developed to counter those obstacles.

Introduction
Functional Anatomy of the Spinal Cord
The spinal cord is composed of over a billion neurons and is responsible for the
conduction of information between the brain and peripheral targets. This information
superhighway comes in the form of an approximately 45cm long soft ovoid shaped tube
that runs from the medulla oblongata at the level of the foramen magnum to typically
the L1 to L2 vertebral level. White matter is located peripherally within the spinal cord
and contains afferent and efferent axon tracts that act as high speed signal conduits.
Gray matter located centrally within the spinal cord contain the cell bodies of many of
these axons or their interneural connections including those involved with motor
control, reflex loops, as well as central pattern generators. In general, afferent sensory
axons and tracts are found in the dorsal aspect of the cord while efferent motor axon and
tracts are found in the ventral aspect. The spinal cord is protected within the bony
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vertebral spinal column. Additionally, the spinal cord is protected and wrapped with the
three meninges, the dura mater, the arachnoid mater, and the pia mater. Spinal cord
enlargements are found at the cervical or lumbar areas, which are responsible for
innervation of the limbs. With the increased circumference of these areas comes
lessened space between cord and bony spine. This is the primary reason spinal cord
injuries are seen more frequently in the enlargements.
Despite the all encompassing name, spinal cord injuries can be the result of
different types actions on the cord. Examples of these are squeezing, tearing, crushing
or cutting. A pathological classification was created relating the manner in which the
cord was injured to the gross appearance and histology of the cord seen at autopsies.
These spinal cord injuries can be clinically classified into four distinct categories. The
four groups include solid cord injuries, contusion/cavitation injuries, laceration injuries
and massive compression injuries (Bunge et al, 1993).

Solid Cord Injuries
Solid cord injuries represent about 10% of all SCI cases. While no gross defects
can be seen, histological analysis typically reveals a loss of normal spinal cord
architecture in the injured region (Figure 1.1B). The cause of solid cord injuries is
unclear, although inflammation is thought to be a key contributor to their development.
It is suggested that light trauma such as stretching or squeezing is enough to trigger
inflammation, a component of secondary injury, which can lead to damage in the spinal
cord tissue.
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Contusion/Cavitation Injuries
The second type of spinal cord injury is contusion/cavitation. This is the most
common type of injury and represents approximately half of all cases. These injuries
are usually caused by a dislocated vertebra or displaced discs and ligaments pressing
into and bruising the spinal cord. Due to the nature of this type of injury, the meninges
remain intact despite the fact that there is often visible bleeding within the central gray
matter. These areas eventually undergo liquefactive necrosis and as the debris is cleared
by inflammatory cells, a fluid filled cyst is formed (Figure 1.1C). At the same time,
astrogliosis occurs in which astrocytes proliferate and hypertrophy forming a gliotic
scar surrounding the cyst.

Laceration Injuries
Laceration injuries represent about 20% of SCI cases. Laceration of the cord
can occur as the result of fragmented vertebra cutting the cord, as well as from stab and
gunshot wounds. The key difference between laceration injuries and contusion injuries
is the disruption of the meninges (Figure 1.1D). As a result, fibroblasts migrate into the
lesion and deposit collagen, creating a mesenchymal scar. It is known that fibroblasts
represent yet another barrier to successful axonal regeneration (Webber et al., 2003).

Massive Compression Injuries
Finally, massive compression injuries represent 20% of SCI cases. In a massive
compression injury (Figure 1.1E), the cord is completely crushed by a significant force.
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As is the case with laceration injuries, the disruption of the meninges represents an
additional obstacle for meaningful recovery.

Clinical Classification
Clinical classification of SCI is based on functional outcome. SCI can be
classified into complete, incomplete or discomplete. Complete injuries typically result
in total paralysis and sensation loss below the level of the lesion. Incomplete injuries
result in some functions preserved below the level of injury, which implies that some
neuronal tracts have gone undamaged. Finally, discomplete injuries appear complete
but patients exhibit some conscious influence on function below the level of injury.
This type of SCI is not fully understood.

Blood supply of the spinal cord
The spinal artery enters the intervertebral foramen and divides into three
branches outside the spinal canal at each segmental level of the spinal cord: the anterior,
posterior and radicular arteries. The radicular arteries enter the dura mater and join with
the 3 major spinal arteries: the anterior median longitudinal spinal artery, right
posterolateral longitudinal artery, and the left posterolateral longitudinal spinal artery on
the surface of the spinal cord. Anastomosis between vessels exist known as the pial
plexus, providing local blood flow (Mautes et al., 2000).
Additionally, central arteries originating from the anterior median longitudinal
spinal artery travel through the ventral median fissure. The anterior medial longitudinal
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spinal artery supplies approximately two thirds of the cross section of the spinal cord.
The posterolateral longitudinal spinal artery supplies the remaining one third including
the dorsal white matter and dorsal horn. An intermediate zone is supplied by one artery
or the other. The spinal cord arteries become arterioles as they enter the cord
parenchyma. The arteriole terminates at the level of the capillary. A basal lamina
surrounds the endothelial cell. These endothelial cells are often surrounded by the
astrocytic foot processes, which help maintain the blood-spinal cord barrier. The blood
spinal cord barrier exists at the level of the capillaries, composed of specialized
endothelial cells with tight junctions between adjacent endothelial cells (Reese and
Karnovsky, 1967).

Treating SCI
Contusion/cavitation type injuries are the most common in clinics. Thus our lab
was most interested in this type of injury, the obstacles that are present and the potential
therapies to address those obstacles. Following an initial traumatic event to the spinal
cord in a percussive injury, a myriad of events occurs.
Inflammation and edema occur quickly. Inflammation within the spinal cord can
lead to apoptosis and exacerbate the damage initially sustained (Dusart and Schwab,
1994; Blight, 1992; Blight et al., 1995). Disconnecting the neuron cell body from its
neurotrophin source results in additional cell death (Berkelaar et al., 1994) Reactive
gliosis occurs in which cell populations surrounding the site of injury undergo
hypertrophy and hyperplasia. These cells form a dense cellular network called a gliotic
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scar. This gliotic scar represents a mechanical barrier to axon growth (Reier et al,
1983). In addition to mechanically blocking axons, reactive astrocytes release
compounds that inhibit neuron growth cones (Apostolova et al., 2006; Pasterkamp et al.,
2001; Hagino et al., 2001; Mckeon et al., 1995). This represents a biochemical barrier to
axon regeneration. Over time as the cell and axon damage registers, cell death occurs
via liquefactive necrosis. The end result of this necrosis is a fluid filled cyst (Figure
1.2). This fluid filled cyst represents a physical gap between the severed axon and its
distal target.

Cell death and loss of neurotrophic support
Neurotrophins are small peptides that act on the nervous system through
intracellular signaling cascades that promote cell survival, growth, and/or differentiation
(Markus et al., 2003). The most widely studied and well understood of the
neurotrophins is nerve growth factor (NGF), however a family of growth factors with
shared sequence homology also include brain derived neurotrophic factor (BDNF) as
well as neurotrophins 3, 4/5 (NT-3, 4/5) (Butte et al., 1998; Ibanez 1994). A multitude
of cells have been shown to express these neurotrophins, both in the CNS and
peripheral tissues. In the CNS, both neurons and glia can express these growth factors
(Pitts and Miller, 2000., Arendt et al., 1995). In the periphery, diverse cell populations
can express neurotrophins, of which only a handful are listed: melanocytes, smooth
muscle cells, lung fibroblasts, and various endocrine tissues (Levi-Montalcini et al
1995, 1996). These neurotrophins expressed in the target tissue are transported by the
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neurons through the axonal projections back to the soma. These neurotrophins act
specifically on both high affinity TrkA, B, and C receptors as well as nonspecifically on
the low affinity p75 receptors (Bothwell 1995). For example, the TrkA receptor is a
transmembrane protein that acts as receptor tyrosine kinase for NGF. Activation of the
tyrosine kinase ends in various downstream cascades that effect PI-3, Src, ras, and PLC
pathways among others (Saltiel, 1994). The result of TrkA receptor binding leads to
archetypal function including cell survival and axon growth cone sprouting. Unlike the
Trk receptors, the p75 low affinity receptors are able to bind to all members of the NGF
family. While the p75 receptor's exact functions are less clear than the Trk receptor, the
p75 receptor binding has been shown to regulate Trk signaling (Dobrowsky et al 1994,
1995). Others state the Trk receptors may act as a sink for excess neurotrophin.
Neurons disconnected from their peripheral targets lose these neurotrophic factors that
are required for survival and often enter programmed cell death (Berkelaar et al., 1994).
It has been shown that neurotrophins in the injured spinal cord react differently
temporally. NGF and BDNF levels quickly decline and only transiently increase in the
weeks to months following injury. NT-3 levels similarly decline; however regain basal
levels by 30 days following injury. In some areas, NT-3 levels have even been shown to
be greater than pre-injury (Zhang et al., 2008). Neurotrophins play a critical role in the
regenerative process, as it has been shown that exogenous neurotrophins after Central
Nervous System (CNS) injury rescue axotomized neurons (Diener and Bregman, 1994;
Vejsada et al., 1995).
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Reactive astrogliosis and the formation of a gliotic scar
Following a contusional SCI, reactive astrogliosis occurs with cellular
hyperplasia and hypertrophy. These cells accumulate close to the site of injury and
form a dense cellular formation that is known as a gliotic scar (Fitch and Silver, 2001).
This glial scar is characterized not only by dense cellularization, but also by the
astrocytic processes that form tight junctions. These tight junctions represent a newly
formed glia limitans, which offers structural support in the separation of healthy CNS
tissue from the necrotic debris at the injury epicenter. This prevents the spread of
necrosis and is beneficial (Fitch et al., 1999; Myer et al., 2006). These astrocytes play
an important role in restoring the ionic balance and clearing excess excitatory
neurotransmitters that have accumulated in the extracellular environment (Norenberg,
1994). Additionally, the reactive astrocytes are instrumental in remodeling the
extracellular matrix (ECM) by laying down deposits of basal membrane. The basal
membrane can contract to bring opposing ends of the lesion closer, reducing the size as
the debris is cleared. Finally, the gliotic scar provides a cellular scaffold for migrating
epithelial and endothelial cells for revascularization of the lesion.
While the gliotic scar has many beneficial functions, it has also been shown to
release compounds that inhibit axonal regeneration such as chondroitin sulfate
proteoglycans (CSPG). The glial cells within the scar up regulate their expression of
CPSG. CPSGs are known inhibitors to axonal regeneration (Mckeon et al., 1995).
Chondroitin sulfate proteoglycan is a sulfated glycosaminoglycan (GAG).
Proteoglycans are simply polysaccharides attached to a core protein. Depending on the
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core protein, the entire molecule takes on a distinctive name. Examples of CPSG
molecules include aggrecan, brevican, neurocan, phosphacan, and NG2. CSPG's are
found in the ECM of most tissues (Tisay and Key, 1999). These molecules are
structural in nature, and important regulators in various biological processes involving
cellular recognition, migration and signaling. In the nervous system, CSPGs contribute
to the regulation of various developmental processes, stopping neuronal and axonal
growth cone migration (Brittis et al., 1992; Cortes et al., 2009). A massive upregulation
of these CSPG's occurs following CNS injuries (Lemons et al., 1999). The levels of
CPSG stay high with the formation of the gliotic scar (Tang et al., 2003). Although the
exact mechanism of inhibition is unknown, it is suggested that the GAG chains are
responsible (Morgenstern, 2002). In vitro experiments using chondroitinase ABC
(chABC), a bacterial enzyme that cleaves these GAG chains, has shown a reduction of
the inhibitory activity of CSPGs (Bradbury et al., 2002). In vivo studies using chABC
have demonstrated enhanced axonal sprouting, neuroplasticity as well as improved
functional recovery in task specific training (Cafferty et al., 2008; Huang et al., 2010;
Lee et al., 2010).

Edema and inflammation
Following SCI, the blood brain barrier is often compromised, resulting in a loss
of cerebral autoregulation and increase in the permeability of capillaries which leads to
accumulation of plasma fluid into the extracellular space. This edema can cause
ischemia that may lead to a buildup of metabolites and excitatory neurotransmitters,
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causing greater cell death (Stiefel et al, 2005). The disruption of the blood brain barrier
evokes a greater post traumatic response by neutrophils and macrophages. In
additional, it further complicates the injury cascade as traumatized endothelial and glial
cells release vasoactive substances such as nitric oxide and histamines. This facilitates
the perfusion of the spinal cord and influences large plasma molecules to enter the cord
(Schnell et al., 1999). Inflammatory cells are attracted to the injury site, with the
earliest arrival of neutrophils occurring within 12 hours (Dusart and Schwab, 1994).
These cells begin to phagocytose much of the cellular and myelin debris. Neutrophils
also release cytokines such as IL-8 in the signaling and recruitment of additional
inflammatory cells (Chollet-Martin et al., 1996; Beeh et al., 2003). These additional
inflammatory cells include resident microglia that hypertrophy and proliferate, as well
as infiltrating lymphocytes and peripheral macrophages. Inflammation is a necessary
component to wound healing, and while the cleanup of cellular and myelin debris is
beneficial, many researchers have claimed that this inflammatory response may be
neurotoxic. Within the inflammatory response, neutrophils release many reactive
oxidative species and hydrolytic enzymes that cause irreversible damage to the CNS
(Hirschberg et al., 1994) and infiltrating lymphocytes are associated with promoting
cellular apoptosis (Popovich et al., 1996).

Cyst Formation
Weeks to months following a contusional SCI, a fluid filled cyst forms. Multiple
cysts may form as the result of a single initial injury. The cysts are surrounded by a
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wall of gliotic scarring and are essentially the final product of the cleanup of debris that
occurs. Similar to cysts, syrinxes may also form as a response to injury. Syrinxes differ
from cysts in that they have pressure build up, which may cause additional
complications. These cavities represent a physical gap in which axons must traverse in
order to reconnect with their distal targets.

Vascular issues associated with SCI
Commonly studied in tumors, angiogenesis is one aspect of SCI that is
immensely important but often overlooked. The restoration of functional vasculature in
the spinal cord following a traumatic event is essential for cellularization and ultimately
axonal regrowth to occur. Vascular Endothelial growth factor (VEGF) is just one an
example of many factors that are involved with the formation of new blood vessels.
Typically in spinal cord injury, local blood flow is disturbed and many cells become
hypoxic. The hypoxic environment causes cells to release hypoxia inducing factors
(HIF) (Hickey and Simon, 2006). It is believed that mitochondrial generation of
superoxide and hydrogen peroxide are required for HIF transcription factors to
effectively upregulate gene expression for the release of VEGF (Chandel et al., 1998,
2000). VEGF binds to VEGF receptors on endothelial cells, activating a tyrosine kinase
cascade that stimulates preexisting blood vessels to break down their basal laminas
using a matrix metalloproteinase. This allows endothelial cells to escape from the
parent vessels and form new sprouts into the surrounding extracellular matrix
(Rosenburg, 1995). These sprouts extend toward the source of angiogenic stimulus and
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anastomoses into loops to become fully functional vessels (Goto et al., 1993;
Matsumoto and Claesson-Welsh, 2001).
Following injury to the spinal cord, the blood-spinal cord barrier is often
compromised. When this barrier is functional, it prevents immune system cells from
entering the central nervous system. This disruption of the blood-spinal cord barrier
can expose the spinal cord to neurotoxic elements associated with inflammatory cells
(Schlosshauer, 1993). Excitatory neurotransmitters such as glutamate or glycine can
also be neurotoxic to cells at high concentrations (Schlosshauer, 1993). The restoration
of the blood-spinal cord barrier takes time and it has been shown that small foreign
compounds are still present in the CNS up to 28 days post injury (Popovich et al, 1996).
As new vessels form, it has been demonstrated that astrocytes are necessary for the
restoration of the blood-spinal cord barrier (Whetstone et al., 2003).
All of the events above represent obstacles to successful spinal cord
regeneration. Due to the complexity of the injury and pathology in the hours to weeks
following, singular approaches have not had success in the past. Combinatorial
strategies offer new hope for the future. Our lab has devised a strategy that addresses
many of the obstacles to spinal cord injury.

A novel therapeutic strategy
The bridge
Contusion injury to the spinal cord results in liquefactive necrosis of the tissue at
the site of injury and often the formation of a fluid filled cyst. This fluid filled cyst is a
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physical gap in which axons can not cross. This is often the endpoint of contusional
SCI and must be addressed for functional recovery. Research groups have explored the
use of varying bridging materials to fill the cyst including: stem cells (McDonald et al,
1999; Akiyama et al., 2002), support cells (Xu et al., 1995; Li et al., 1997), autologous
grafts (von Wild and Brunelli, 2003; Houle et al., 2006), embryonic grafts (Reier et al.,
1986) or synthetic substances (Tsai et al., 2004; Wen and Tresco, 2006).
While many of these approaches have shown axon growth, few axons have been
able to reach the tissue on the opposing end of the bridge. In creating an appropriate
bridge for axons in the healing SCI scenario, the material must be biocompatible and
allow if not direct axons to grow directionally across. The bridge must be three
dimensional and fill the extent of injury, while still porous enough for axons and cells to
infiltrate. Finally, this bridge should be compatible with a method for delivery of
compounds beneficial to neuroprotection or axonal regeneration.
One method that fulfills all of these requirements is a process called
electrospinning. Electrospinning uses a high voltage electric field to generate fine
fibers that are deposited on a grounded rotating mandrel to form a cloth like matrix
(Bowlin et al., 2002). The electrospinning apparatus is shown in figure 1.3A. These
fibers can be composed from extracellular matrix proteins or synthetic polymers.
Properties of these electrospun structures, such as fiber diameter, porosity and
alignment can be adjusted (Fridrikh et al., 2003). Electrospinning has been used in
tissue engineering in many different applications such as dermal implants or synthetic
vessels (Stizel et al., 2001; Sun et al., 2005). The synthetic polymer chosen for use in
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spinal cord injury is a resorbable suture material polydioxanone (PDS). PDS is
biocompatible and has a lifespan in vivo of approximately 6 months (Molea et al, 2000;
Boland et al., 2005).
A drawback to the use of the electrospinning apparatus is the inability to create
an implant that matches the size and morphology of the spinal cord. To address this
issue, a modification was made to the ground as shown in figure 1.3B. The mandrel
was replaced with two grounded posts, resulting in the fibers whipping around each post
in succession and creating a cylindrical scaffold with the fibers aligned along its length.
A Scanning Electron Micrograph taken of the fibers is shown in figure 1.4, displaying
the porosity of these fibers in the matrix.
These bridges were tested for their ability to support neurite outgrowth in vitro.
Using dorsal root ganglions (DRG) taken from neonatal rats, we were able to show that
not only could DRGs survive on these electrospun matrices, but that the neurites were
also directed by the alignment of the fibers (Figure 1.5A)(Chow et al., 2007). However,
these outgrowths soon degenerated without appropriate trophic support (Figure 1.5B).
In order to support axons growing through the electrospun matrix, the matrix had to be
supplemented with neurotrophic factors that promote the survival of neurons. Such
neurotrophic factors play a significant role in the CNS following trauma (Dougherty et
al., 2000; Krenz and Weaver, 2000). In order to supplement our electrospun implant
with bioactive neurotrophic factors, alginate was used as a vehicle for delivery.
Alginate is a gum found in cell walls of certain brown algae and seaweeds that is used
in industrial, food processing, and biomedical applications such as a waterproofing,
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thickening, or detoxification agent. Alginate is biocompatible and can be utilized in
vivo. Nearly all proteins of interest can be encapsulated in alginate and dehydrated,
providing sustained release of protein upon hydration (Noushi et al., 2005). We could
show the extent of protein incorporation by simply placing a FITC conjugated protein in
the alginate (Figure 1.6). Furthermore, we ran a simple dorsal root ganglion bioassay
experiment to demonstrate that these proteins encapsulated within alginate by
electrospraying remained bioactive upon rehydration (Ayres et al., 2010). NGF was
clearly shown to be released from alginate beads in vitro (Figure 1.7), and in a form that
could effect the growth of the DRG (Figure 1.8). A final component to our bridge
required we address the issue of the inhibitory compounds being released by the
reactive astrocytes in the gliotic scar surrounding the cyst. Chondroitinase ABC
(chABC) is an enzyme that cleaves the GAG chains from the neuroinhibitory CSPGs.
It has been shown that this functions to decrease the inhibitory activity, and several in
vitro as well as in vivo studies have established that this enzyme facilitates axonal
regeneration. In a series of experiments, we demonstrated that we could incorporate
chABC into our electrospun implants and the enzyme remained bioactive (Figure 1.9).
Having demonstrated the potential various beneficial utilities of using an
electrospun matrix in a spinal cord injury setting, we hypothesize that by using a 3-D
airgap electrospun matrix in a rat given a complete transection spinal cord injury, we
could increase functional recovery and correlate the increase to axon and vascular
growth into the implant.
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Figure 1.1. Pathology of the Spinal Cord. Histology (A) Cross section of a normal
human spinal cord at the cervical level. (B) Loss of spinal cord architecture seen in
solid cord injuries. (C) Formation of fluid filled cavities in contusion/cavitation
injuries. (D) Disruption of Pia in laceration injuries. (E) Loss of tissue and hemorrhage
in massive compression injuries. Scale Bars (A to E) = 2 mm. (Norenberg et al., 2004)
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Figure 1.2. The Cystic Cavity. (A) A schematic of the glial scar and cavity that form
post injury. (B) Section of an injured rat spinal cord 2 weeks following injury.
Astrocytes are shown in green, cell bodies in blue and chondroitin sulfate proteoglycans
in red. Figure 1a was modified from McDonald et al., (1999).
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Figure 1.3. The Electrospinning Apparatus. Key system components include a
solution reservoir (syringe), nozzle (18-gauge, blunted, metallic needle), high-voltage
DC power supply, and grounded target (rotating mandrel). (A) The original
electrospinning apparatus with rotating mandrel for fiber collection. (B) The airgap
electrospinning apparatus. The grounded mandrel is replaced with two grounded posts.
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Figure 1.4. SEM of PDS Matrix Monofilaments. (A) SEM showing aligned fibers in
a representative matrix. Fiber diameters can be seen here varying greatly, but generally
held to under 3 µm. (B) SEM taken of a PDS matrix cut in cross section. Fibers are
packed densely but with porosity for cells and axons to grow through. Scale bar (A)=2
um, (B)= 10 um.
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Figure 1.5. Electrospun matrices support neurite outgrowth. (A) A pinned DRG
immunostained for TuJ1 on an electrospun matrix. Directionality of neurite outgrowth
is influenced by aligned fibers. (B) A pinned DRG's neurite outgrowths are seen
degenerating 1 week without neurotrophic support. Scale bar B = 10µm

27

28

Figure 1.6. Alginate microspheres. (A) A light microscopic image of the alginate
carrier beads. (B) A wide-field fluorescence image of the same alginate carrier beads
showing the incorporation of a fluorescent protein. The white arrows point to the same
piece of debris, indicating the same field of view in both images. Scale Bars (A and B)
= 10 μm.

29

30

Figure 1.7. Alginate microsphere release kinetics for NGF. NGF ELISA measures
NGF released by alginate beads + NGF over 6 time points. NGF release is greatest in
the first 3 days following hydration, but continues to release NGF up to 14 days.
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Figure 1.8. Results for NGF bioassay. Results of Bioassay on Alginate
encapsulated NGF on DRG outgrowth. (A) and (C) are schematics equating to (B)
and (D) respectively. In (B) no outgrowth is seen in media without NGF. In (D), robust
outgrowth of neurites is seen when NGF is delivered in the alginate carrier beads. Scale
bar = 500 μm
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Figure 1.9. Results for chABC strip bioassay. Strip bioassay of dorsal root ganglia
(green) grown between aggrecan lanes (red) for 7 days in culture. Aggrecan is a CSPG,
is a known axon inhibitor. (A) is a schematic of the strip bioassay. (B) and (C) are the
corresponding results. In the absence of chABC, DRG neurites were inhibited from
growing on aggrecan lanes. However; the presence of a chABC in the matrix reduces
the inhibition. Arrows denote boundaries of aggrecan. Scale Bars (B and C) = 500 μm.

Chapter 2
Materials and Methods

Air Gap Electrospinning:
PDS (monofilament suture, Ethicon) is dissolved in 1,1,1,3,3,3 hexafluoro-2propanol (Sigma-Aldrich) at a concentration of 100 mg/ml.

This electrospinning

solution is loaded into a 5-ml syringe (capped with an 18-gauge blunt end needle) that is
mounted into a syringe pump. The needle is connected to a high voltage, low amperage
DC power supply (Spellman CZE1000R) via an alligator clip and charged to 22kV. A 2
pole system consisting of grounded horizontal piers that are separated from one another
by a 5-10 cm gap (Figure 1.2B) is used (Ayres et al., 2008). This system produces
cylindrical constructs composed of individual fibers with cross-sectional diameters
ranging between 1 to 3 µm. These fibers are deposited across the gap that separates the
grounded piers into arrays that are oriented in parallel with the long axis of the
constructs.

Creation of PGLA capsule:
Following the creation of an electrospun matrix with the airgap electrospinning
technique, a second copolymer Polyglycolic-Lactic Acid (PGLA) consisting of 50%
polyglycolic acid and 50% polylactic acid is prepared as stated above. The 2 pole
system is removed and a grounded plate is placed at a distance such that the newly
formed matrix is between the charged needle and grounded plate. When the voltage is
35
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applied, the PGLA copolymer is electrosprayed towards the grounded plate. The PDS
matrix is rotated so that PGLA is able to coat evenly.

Creation of Alginate Beads containing growth factors:
Alginate beads were generated with an electrospraying technique (Ayres et al.,
2010). An appropriate quantity of the solute of interest was added to 300 µl solution of
0.005-mg/ml sodium alginate and 0.005-mg/ml protease-free bovine serum albumin
(used as a carrier). The solution was then loaded into a 1-ml syringe tipped with an 18gauge blunt-end needle (Kontes) installed onto a syringe driver. The needle was
connected to an anode of a high voltage direct current power supply (Spellman
CZE1000R) via a wire outfitted with an alligator clip. A 150-mm glass Petri dish filled
with 2% calcium chloride solution was placed on a metal plate. By switching the power
supply on, an electric field was formed which pulls the alginate solution out of the
syringe as an aerosol mist and into the calcium chloride solution. Upon contact with the
calcium the alginate forms into a bead that traps the solute (growth factor) of interest.
The beads were collected, washed by centrifugation in a 2% calcium chloride solution
supplement with 10% isopropanol, washed in Hexafluoroisopropanol (HFIP) and
lyophilized.

DRG bioassay for NGF
To test if the Nerve Growth Factor (NGF) encapsulated within the alginate
microspheres remains bioactive, Dorsal Root Ganglions (DRG) extracted from neonatal
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rats were placed into poly-L-lysine coated wells in a 48 well plate. Following
rehydration in culture media, alginate microspheres with NGF were placed into
Transwell inserts. These inserts were placed into wells containing the DRGs. Alginate
microspheres with Bovine Serum Albumin (BSA) were used to act as controls.
Incubation media was composed of Eagle's minimum essential medium with glutamine
supplemented with 10% glucose and 5% Fetal Bovine Serum (FBS). Additional
negative and positive controls were set up by incubating DRGs with media
supplemented with and without NGF. This assay was performed with three times per
animal with E16 DRG's from four different animals. To visualize the DRGs, the
cultures were fixed with 4% paraformaldehyde and immunolabeled for beta-tubulin
neuronal marker TuJ1 (Covance).

DRG bioassay for chABC
To test if chABC remained active following electrospinning, a strip bioassay was
used. Aggrecan, a CSPG known to inhibit axonal growth was deposited in a strip lane
onto a poly-L-lysine coated Thermanox coverslip. DRGs were pinned onto the
coverslips between these aggregan lanes and placed into Petri dishes with DRG culture
media. Matrices were electrospun such that chABC was incorporated. These matrices
were placed into experimental petri dishes, while control petri dishes only contained
BSA matrices. The assay was performed three times per animal with E16 rat DRG's
from four different animals. To visualize the DRGs, the cultures were fixed in 4%
paraformaldehyde and immunolabeled for the beta-tubulin neuronal marker TuJ1
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(Covance).

Animal Procurement and treatment:
All animal work was done following a VCU IACUC approved protocol. All
animals were obtained from Harlan Inc. The animals used in chapter 1 were 60 day +/5 day old female Long Evans Hooded rats. The animals used in chapter 2 were 100 day
+/- 10 day old female Long Evans Hooded rats.

Surgical Procedure:
The rats were first anesthetized with 5.0% Isofluorane (AERANE) in a gas
chamber and kept under for the duration of the surgery using a nose cone with 3.0%
isofluorane. A rectal temperature probe will be placed and the animal put on a warming
blanket. Aseptic conditions were made by shaving the back of the rat and washing the
skin with betadyne. A dorsal midline incision was made through the skin to expose the
muscles of the back. An additional two incisions were made in order to expose the
spinous process of the vertebrae. Tissue spreaders were used to expand exposure and
access to the vertebrae. The T8 vertebra was then confirmed via palpation of the back.
Using rongeur's, a laminectomy was performed, removing the lamina, transverse
processes and exposing the spinal cord. We then performed a transection of 3.5mm +/0.5mm of the spinal cord, and replaced the cord with a 4mm portion of our electrospun
matrix. Following implantation, the muscular layers were closed with silk suture
(Ethicon). The skin was stapled shut with mitchell staples (FST). Antibacterial cream
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(Bacitril) was spread over the incision to prevent infection.

Post Operative Care:
Post surgical rats were placed on a heat pad and monitored until conscious, and
given an injection of gentimycin (10mg/kg) and buprenorphine (0.5 mg/kg).
Buprenorphine was administered every 12 hours for the first 48 hours. Following
surgery, rats were given daily prophylactic injections of gentimycin for 7 days to
prevent bacterial infection. The water was supplemented with acetaminophen
(150mg/kg) for 3 days post operation. Urine was voided from the bladder by manual
stimulation twice a day until the rats began to self micturate (urine volume measured at
<2 ml/day). Urinary tract infections were diagnosed and treated with 5 day cycles of
gentimycin.

Basso-Beattie-Bresnahan locomotor rating scale:
The BBB scale is a well-known animal behavioral test. The rats are assessed for
hind limb locomotor skills and scored on a 21-point system, with 0 being complete hind
limb paralysis and 21 being complete mobility (Table 1.1). This test rates parameters
such as joint movements, weight support, limb coordination, and gait stability. Animals
were evaluated pre-operatively for four minutes in an open field using this scale, to
ensure they are free of motor deficits. To perform the test, animals are placed in an open
field (large round tabletop with high barrier on edge) and allowed to ambulate to the
degree they are able for a four minute period. The animals were evaluated bi-weekly
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for the duration of the experiments (1-12 weeks).

Tissue Collection:
Rats were euthanized using a pentobarbitol agent Euthasol (150mg/kg) injected
intraperitoneally to induce a general plane of anesthesia and perfused transcardially
with 0.1 M phosphate-buffered saline (PBS) and fixed with either 4% paraformaldehyde
for immunohistochemistry or a 4% paraformaldehyde and 1% gluteraldehyde mixture
for electromicrography. Spinal cords were then dissected out and allowed to further fix
in paraformaldehyde or paraformaldehyde/gluteraldehyde mixtures for 48 hours at 4° C.
The Spinal cords were then transferred into a 30% sucrose solution for 24 hours at 4° C.
20µm thick longitudinal sections of the implantation and immediate bordering spinal
cord sections were taken on a cryostat, with sections representing 100µm out of every
500µm through the cord.

Immunohistochemistry:
Several antibodies were used to identify the cell population in the injury site.
Astrocytes, microglia, schwann cells, axons, and fibroblasts were identified with
GFAP(1:1000), IBA-1(1:1000), S100(1:500), Smi31(1:1000), and Fibronectin (1:100)
respectively. All sections were blocked with 4% normal goat serum, rinsed with PBS,
incubated in primary antibody overnight at 4°C, rinsed with PBST, blocked again, and
incubated for 2 hours with Alexa Fluor 488 or 568 fluorescent conjugated secondary
antibodies (Invitrogen). Sections where then counter stained with 4',6-diamidino-2-
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phenylindole (DAPI), and coverslipped with mounting medium (Vectashield). Smi31
antibody (Covance) for Neurofilament Heavy required a non-phosphorylated block and
rinse, Tris Buffered Saline was used instead of Phosphate Buffered Saline.
Vasculature was identified in principle by the identification of Red Blood Cells
(RBC). RBCs were identified by utilizing their native glutathione peroxidase activity.
A DAB peroxidase mixture (0.05% DAB with 0.015% H2O2) was placed onto each
section for variable time to allow visualization through brown crystalline precipitate.
The use of immunohistochemistry in these experiments was to demonstrate the presence
of cell populations and was not quantified.

Electron Microscopy:
For EM, the transection/implantation site was post-fixed in buffer
glutaraldehyde and then in 1% OsO4 for 1hr, dehydrated through an ethanol series and
infiltrated overnight in epon/araldite. 1µm “semithin” sections were obtained and
stained with toluidine blue. Coronal thin sections were used to determine the diameter
of monofilaments within the middle of the implant. Monofilament diameters were
measured by taking 9 representative grids through the middle of the implant. Fibers
were measured using a scale bar.
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BBB Locomotor Rating Scale
0
No observable hind limb movement
1
Slight movement of one or two joints, usually the hip and/or knee
2
Extensive movement of one joint or extensive movement of one joint and slight movement of one other
joint
3
Extensive movement of two joints
4
Slight movement of all three joints of the hind limb
5
Slight movement of two joints and extensive movement of the third
6
Extensive movement of two joints and slight movement of the third
7
Extensive movement of all three joints of the hind limb
8
Sweeping with no weight support or plantar placement of the paw with no weight support
9
Plantar placement of the paw with weight support in stance only (i.e., when stationary) or occasional,
frequent, or consistent weight supported dorsal stepping and no plantar stepping
10
Occasional weight supported plantar steps, no forelimb-hind limb coordination
11
Frequent to consistent weight supported plantar steps and no forelimb-hind limb coordination
12
Frequent to consistent weight supported plantar steps and occasional forelimb-hind limb coordination
13
Frequent to consistent weight supported plantar steps and frequent forelimb-hind limb coordination
14
Consistent weight supported plantar steps, consistent forelimb-hind limb coordination; and predominant
paw position during locomotion is rotated (internally or externally) when it makes initial contact with the
surface as well as just before it is lifted off at the end of stance or frequent plantar stepping, consistent
forelimb-hind limb coordination, and occasional dorsal stepping
15
Consistent plantar stepping and consistent forelimb-hind limb coordination; and no toe clearance or
occasional toe clearance during forward limb advancement; predominant paw position is parallel to the
body at initial contact
16
Consistent plantar stepping and consistent forelimb-hind limb coordination during gait; and toe clearance
occurs frequently during forward limb advancement; predominant paw position is parallel at initial contact
and rotated at lift off
17
Consistent plantar stepping and consistent forelimb-hind limb coordination during gait; and toe clearance
occurs frequently during forward limb advancement; predominant paw position is parallel at initial contact
and lift off
18
Consistent plantar stepping and consistent forelimb-hind limb coordination during gait; and toe clearance
occurs consistently during forward limb advancement; predominant paw position is parallel at initial
contact and rotated at lift off
19
Consistent plantar stepping and consistent forelimb-hind limb coordination during gait; and toe clearance
occurs consistently during forward limb advancement; predominant paw position is parallel at initial
contact and lift off; and tail is down part or all of the time
20
Consistent plantar stepping and consistent coordinated gait; consistent toe clearance; predominant paw
position is parallel at initial contact and lift off; tail consistently up; and trunk instability
21
Consistent plantar stepping and coordinated gait, consistent toe clearance, predominant paw position is
parallel throughout stance, consistent trunk stability, tail consistently up
Terms and Operational Definitions
Slight
partial joint movement through less than half the range of joint motion
Extensive
movement through more than half of the range of joint motion
Sweeping
rhythmic movement of hind limb in which all three joints are extended, then fully flex and extend again;
animal is usually lying on its side, the plantar surface of paw may or may not contact the ground; no weight
support across the hind limb is evident
No Weight
no contraction of the extensor muscles of the hind limb during plantar placement of the paw; or no
Support
elevation of the hindquarter
Weight Support
contraction of the extensor muscles of the hind limb during plantar placement of the paw, or elevation of
the hindquarter
Plantar Stepping
paw is in plantar contact with weight support then the hind limb is advanced forward and plantar contact
with weight support is reestablished
Dorsal Stepping
weight is supported through the dorsal surface of the paw at some point in the step cycle
forelimb-hind
for every forelimb step an hind limb step is taken and the hind limbs alternate
limb
Coordination
Occasional
less than or equal to half; <50%
Frequent
more than half but not always; 51-94%
Consistent
nearly always or always; 95-100%
Trunk Instability
lateral weight shifts that cause waddling from side to side or a partial collapse of the trunk
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Table 1.1. The 21-point BBB locomotor scale used to rate functional recovery after
SCI. (Chow, 2009)

Chapter 3
Exploring the Histology of Electrospun Implants In Vivo

Introduction
There exist a myriad of obstacles facing successful therapy to spinal cord injury.
Following spinal cord injury, damaged axons are separated from their source of
neurotrophic support, which results in additional cell death. At the gliotic scar
surrounding the damaged tissue, neuroinhibitory compounds such as chondroitin sulfate
proteoglycans are expressed which inhibit growth cones in regenerating axons. Finally,
the formation of a fluid filled cyst represents a gap where axons have no substrate to
grow on. In order to address these issues, we demonstrated the ability to create an
implant using a process called airgap electrospinning with PDS as a substrate.
Additionally, these implants were able to direct neurite outgrowth, contain bioactive
neurotrophic factors and enzymes to reduce the activity of the neuroinhibitory
compounds. This represented a novel combinatorial approach to spinal cord injury.
Nerve growth factor (NGF) is essential for the growth and survival of sensory
neurons that project their axons through the dorsal columns (Acosta et al., 2001;
Tusynski et al., 1994). For the first set of experiments, we used an airgap electrospun
matrix made with PDS, and supplemented these with alginate microspheres containing
NGF and chABC.
To test these matrices, we opted to use a complete transection model for SCI.
While a complete transection rarely happens in the clinical setting, this model is
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nonetheless the preferred model in the laboratory because the functional deficits are
reproducible and recovery can be attributed to regeneration following injury rather than
axon sparing.
While individuals suffering from spinal cord injury have a plethora of health problems
extending beyond paralysis, motor function is perhaps the easiest deficit to visualize as
well as score.
The BBB test is an open field locomotor test named after Basso, Beattie and
Bresnahan that rates the quality of hindlimb movements (Basso et al., 1995). In this
experiment, we used the BBB test to show animals with implants fortified with NGF
and chABC scored better than those with only implants or no implants at all. While
these animals showed functional recovery, these implants had never been given a
histological examination. In this chapter, we analyzed tissue sections of rats given our
spinal cord implant following a complete transection injury to gain greater
understanding of how the implant's monofilaments interact with host tissues and cells.
Axons were discovered within every segment of our implant. As every axon had been
severed in our SCI model, we also examine the level of axon degradation rostral and
caudal to the level of the injury to determine differences in axon tract survival. Finally,
we discover the presence of functional vascular supply supporting the cellularization
and axonal growth into the implant.

Results
The spinal cords and implants were very well integrated upon gross examination
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following dissection, with all cords being extracted as one continuous object. While
scar tissue was present, it was quite minimal and confined to the cord. Implants did
vary in their sizes, a result of the electrospinning process forming an imperfect cylinder.

Monofilament interaction with the spinal cord:
The airgap electrospinning process had been shown to create fibers of
approximately the same diameters with a densely packed formation (Figure 1.4). Fiber
diameters were stated to be confined up to 3µm. However, upon examining the fibers at
the EM level post implantation, we were able to show great variation in size of these
fibers (Figure 3.2). Analysis of these fibers at the EM level show a variety of fibers of
all sizes, measured up to a 60 fold difference in fiber size. The graph in Figure 3.2
weighs percentage of fibers to their diameter. A scattering of fiber sizes is prevalent
throughout the implant, with over 60% of fibers having diameters 6 µm or lower. This
does not prevent fibers from being spun at a much larger diameter, with the largest fiber
diameter measured at 32 µm. Figures 3.2A, 3.2B, and 3.2C show three different fibers
in the same section. All three images were taken with the same magnification to show
the variability in fiber diameters. Figure 3.2A is centered on a fiber 2 µm in diameter,
but below it are two other fibers that are approximately 1 and 0.5 µm in diameter.
Figure 3.2B shows a fiber with a diameter of 10 µm, while Figure 3.2C shows a fiber
measuring 25µm in diameter. These are representative images of monofilaments that
can be found readily. Within the implant, monofilaments can be found in clusters that
exhibit uneven spacing. No correlation exists between fiber diameter and location
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within the implant. Using a cross section of the spinal cord at the rostral border with the
implant, a distribution favoring the periphery of the spinal cord exists. These fibers can
be seen in greater number in the peripheral white matter (figure 3.3). This section was
taken in spinal cord, thus the gray and white matter can be clearly seen. Curiously,
there are very few monofilaments seen in the gray matter. As cell mass is higher in the
gray matter, it is possible that the cells infiltrated the matrix centrally, pushing
monofilaments peripherally. With the greater abundance of cells in gray matter, it also
stands to reason microglia and macrophages engulf the implant at the gray matter
scaffold interface to a greater degree than at the white matter scaffold interface.
Monofilament breakdown and degeneration occurs over time, however there is no
consistent pattern to their degradation. In figure 3.4, fibers undergoing degradation are
seen at both the LM and EM level. These fibers display degeneration from central to
peripheral, as well as peripheral to central. Some fibers appear to crack and fragment
into pieces whereas other fibers can be found within a larger space of geometric
similarity to their current shape, suggesting a uniform degradation from the periphery
inward. Larger fragments of monofilament may be engulfed by macrophages. At the
EM level, figure 3.4 also displays the extent to which ECM is laid down surrounding
the fibers. There is no space between fibers and host cells or ECM, indicating the
electrospun PDS is highly biocompatible.
The cells infiltrate the matrix over time, and interact well with the electrospun
fibers readily, as seen in Figure 3.5. Using DAPI to visualize nuclei, alignment of fibers
in the implant affects cell infiltration. Figure 3.5A shows a portion of our electrospun
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matrix that is highly aligned 3 weeks post implantation. Figure 3.5C is that portion of
the matrix with DAPI applied, and cells are seen throughout the entire segment. Figure
3.5B shows a portion of the same matrix that has become unaligned. This nonalignment
may have occurred during the spinning process. Utilizing DAPI, we can hardly see any
cells within this unaligned segment (Figure 3.5D). This shows that misalignment of
monofilaments during spinning may prevent cells from entering and disrupting the
continuity of the cellularization within the matrix.

Axons:
Axons are found throughout the extent of the implant. Myelinated axons can be
seen coursing through the middle of the matrix in figure 3.6. While no normal spinal
cord architecture exists within the implant, it is encouraging that so many axons were
found in the implant. This shows the implant has succeeded in its function for
providing a substrate for axons to grow through. It is unknown if these axons are
continuous to the other side because of the disruption from what appear to be
fibroblasts.
Axon tracts above and below the lesion could be seen in differing levels of
degradation. Figure 3.7 compares the dorsal column above and below the level of the
lesion. The axon tracts are highly degraded rostral compared to caudal to the injury.
Macrophages are seen at the arrows enhancing myelin debris cleanup. Figure 3.8 shows
the reticulospinal tract, where many axons have been preserved quite well compared to
the dorsal column, however a difference is seen rostral vs. caudal. In congruence to the
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idea that axon tracts connected to their somas remain preserved better than the axons
disconnected, the reticulospinal tract is in far better condition rostral to the lesion
compared to caudal. Some tracts are degraded both above and below the level of the
implant equally, suggesting differential survivability of axon tracts. This suggests that it
may be essential to target axon tracts independent of one another.

Vascular supply:
The existence of a functional vascular network was discovered in the implants.
This is important for long term glia and neuron survival through the implantation. It
appears that endothelial cells associate themselves with monofilaments to help direct
their growth. Figure 3.9C shows an EM level of an endothelial cell wrapped around a
fiber. Many endothelial cells can be seen either wrapped around a monofilament, or
with a monofilament within the lumen of a presumptive blood vessel. This may suggest
that at one time this monofilament occupied the entire space of the lumen and degraded
over time. While these endothelial cells can use monofilaments, there are many similar
sized monofilaments without endothelial cells associated with them. It appears that
endothelial cells tend to associate with monofilaments within a restricted range of
diameter, however not all monofilaments at these sizes can be seen associating with
endothelial cells. Figure 3.9D shows a fiber of similar size without an endothelial cell
associated with it. To prove that these EM image are in fact of endothelial cells, Figure
3.9B shows blood supply within the matrix at the LM level. Biconcave RBCs can be
seen within the lumen that still has 2 monofilaments inside. This shows that these
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endothelial cells that are using these monofilament fibers as substrates for growth are
doing so in a novel manner, and anastomosing to form functional blood supply within
the implant.
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Figure 3.1. Recovery following surgery and implantation. BBB scores of
experimental animals that were either given an electrospun implant containing NGF and
chABC, an electrospun implant with alginate beads only, or no implant at all. 7 days
post injury animals show little to no hindlimb movement. By 21 days, appreciable
differences have emerged. Animals with no implant show no hindlimb movements.
N=1, 3, 3 for no implant, implant, implant +NGF + ChABC.
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Figure 3.2. Electrospun monofilament diameters. The graph indicates % of total
fibers in relation to their diameter when measured at the EM level using a scale bar.
Representative sections were analyzed throughout the section, N=125 per section
analyzed. Image (A), (B), and (C) are at the same magnification, demonstrating a high
level of fiber size variability. (A) contains a monofilament of 2 µm diameter in the
center, however below this monofilament are two smaller monofilaments with
diameters as small as 0.5 µm. The monofilament in (C) is measured at 20 µm, which is
the largest that could be fit at this magnification. Monofilaments were found up to 32
µm. (Scale bar = 2 µm)
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Figure 3.3. Electrospun monofilament distribution. (A) Cross section of the spinal
cord immediately rostral to the implantation. Monofilaments can be seen throughout
this segment of the spinal cord. (B) denotes every monofilament found in this section
visible to the eye at 20x under LM. A distribution exists favoring the peripheral white
matter. Note that at this level monofilaments with diameters less than 1 µm may not be
visible to the eye.
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Figure 3.4. Monofilaments at varying levels of degradation. Monofilaments can be
seen degrading at the (A) LM or (B and C) EM level. These monofilaments display a
variety degenerative properties, and with no recognizable specificity. In image (A),
neighboring monofilaments exhibit great levels of degradation, or no degradation at all.
Degradation is occurring centrally as seen in image (C).
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Figure 3.5. Aligned fibers affect cell infiltration. This image demonstrates the effect
of alignment in the electrospun matrix has on cell infiltration. (A) and (B) are phase
images of the alignment of a portion of the same implant. Within this implant, (A) is
highly aligned, whereas (B) has is unaligned. Using DAPI, we can see the cell
infiltration difference. Cells have infiltrated the extent of the aligned portion as seen in
(C). However, cells can not enter the implant when the fibers are unaligned as seen in
(D). Scale bar (A-D) = 100 um.
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Figure 3.6. Cross section through center of implant. Axons can be seen at the LM
level at 40x magnification in cross section through the middle of the implantation. This
tissue is highly irregular. There appear to be many round empty spaces around the size
of capillaries present in this image, however, these spaces do not contain endothelial
cell bodies. These could represent the space in which monofilaments once resided. Of
particular interest are unmyelinated axons found in this section of the implant. Scale
bar = 100 um.
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Figure 3.7. Comparison of the Gracile Fasciculus. This image depicts a comparison
of the gracile fasciculus (A) caudal and (B) rostral to the level of the implant. Myelin
degradation has occurred in both levels of the spinal cord, however a greater percentage
of macrophages exist in the rostral cord. Very few myelinated axons can be seen in (B)
whereas there are still plentiful myelinated axons is (A). Scale bar = 100 um.
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Figure 3.8. Comparison of the Reticulospinal tract. This image depicts a comparison
of the Reticulospinal tract (A) Caudal and (B) Rostral at the light microscope level
using 40x magnification. Similar to the dorsal column, the reticulospinal tract has
undergone some level of degradation. Since the cell bodies of this axon tract originates
in the reticular formation rostral to the injury, the axon tracts are predictably preserved
greater in (B) than (A). Scale bar = 100 um.
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Figure 3.9. Endothelial cells wrap around monofilaments. Endothelial cells wrap
themselves around monofilaments in the creation of new blood vessels. (A) is a cartoon
of an endothelial cell and the astrocytic foot processes, the tight junctions represent the
blood spinal cord barrier. Image (C) is an EM of an endothelial cell that has wrapped
around a monofilament. There is no space between the monofilament and the cell body.
Not all monofilaments of this size have endothelial cells associated with them. (D) is a
monofilament without an endothelial cell associated with it. It can be seen degenerating
from the periphery inward. (B) is a LM image depicting a blood vessel with arrows
pointing at the monofilaments still in the blood vessel. RBCs can be seen in the lumen.
Scale bar (B) = 10 um, (C and D) = 0.5 um.
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Discussion
Spinal cord injury has many obstacles to successful regeneration including the
fluid filled cyst, neuroinhibitory compounds and cell survival following axotomy. In
this experiment, we addressed these obstacles by creating an electrospun matrix
containing neurotrophic support that was implanted into completely transected rats. We
sought to elucidate questions and concerns regarding the use of both electrospinning to
create a spinal cord implant, and the use of a complete transection in vivo. With the
help of an experience neurosurgeon, the mortality rate during the operation was less
than 10%. Rats were capable of surviving 12 weeks post injury before being sacrificed
for tissue collection. We showed that the fibers created during electrospinning were
able to associate with the host tissue in a very seamless fashion. Perhaps of greater
significance, we showed that axons grew through the implants. Finally, we were able to
show that functional vascular supply was present in the implant.
One of the first observations we noted was that the fiber diameters were not
uniform as predicted. Having fibers of different sizes may not be deleterious. While
cells have had no trouble entering the scaffold, it is not known if a relationship exists
between cell type and fiber diameter. Endothelial cells appear to utilize smaller
diameter fibers by wrapping themselves around to create a vessel. The lumen becomes
functional when the fiber degrades. It appears that capillaries formed by endothelial
wrapping may come in unnatural sizes as the lumen of the newly formed blood vessel
takes on the size of the original fiber. If these fibers become larger, rarely are there cells
surrounding them. Within the implantation, there are no areas of empty space. Cells
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and ECM have literally pressed right up against these fibers, showing beautiful
integration of synthetic tissue with biological tissue. However, differing degradation
rates make these spaces between fibers variable over time; this suggests that as fibers
degrade, cells or ECM must take their place. This would be further beneficial as long
term remodeling is taking place in the system. With fibers of different sizes, it is
expected that the smaller fibers would degrade at different rates than the larger fibers,
though we are unable to confirm this. In analyzing the matrix 12 weeks post injury and
implantation, there are both small and large fibers in varying states of degradation. Due
to our limited number of experimental animals processed for EM, it is unknown if the
smaller fibers were larger at one time and degraded from the outside in at a constant
rate, maintaining morphology. A chronicling of the matrix in vivo with varying time
points would be necessary to understand the change in fiber distribution and diameter
over time. That being said, it is peculiar that within spinal cord tissue removed from the
injury, fibers can be found. In the section rostral to the transection, we clearly show the
electrospun monofilaments present throughout both gray and white matter, but with a
much greater distribution toward the peripheral edges of the spinal cord. It is possible
that infiltration of cells begins from the gray matter where there is a greater abundance
of cells, which in turn could cause the fibers to spread outward towards the periphery.
Another possible explanation is that fibers degrade quicker centrally. We hypothesize
that because these fibers extend into the spinal cord tissue, they may act as an anchor
for cells to infiltrate the implant.
Cell infiltration is one of the necessary aspects for any spinal cord implant to be
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successful. With the ultimate goal of axon regrowth, glia must be able to enter and
survive in the implant. While fibers are typically electrospun in an aligned fashion,
variables such as moisture in the atmosphere can affect the electric field and result in
fiber misalignment. Damage associated with surgery may also crush or damage the
alignment of the implants. This is to be taken into consideration for future experiments
attempting to cellularize the implants prior to implantation. Our images show that
within a single matrix, areas of alignment and nonalignment may be present. The cell
infiltration greatly varies depending on this alignment. It is essential then, that these
implants need quality control prior to their implantation, and extra care must be taken to
prevent damage during surgery. Mechanical damage to the implant during or prior to
surgery can cause breaches in the fibers and cells to infiltrate from outside the CNS.
This is especially troubling due to the fact that the meninges in our SCI model are
completely removed along with the spinal cord. It was observed that axons running
through the implant eventually may have met a scar of mesenchymal origin through a
segment of the implant that may have suffered from crushing or infolding, which
disrupted axons from traveling directly through. This brings the potential for cells to
enter the matrix that enter from the dorsal/ventral aspect of the implant, rather than from
the rostral or caudal edges where we design entrance to occur. By having all the fibers
aligned, it stands to reason that axons entering one end would be directed straight
through the implant without excessive diversions or branchings. Having
compartmentalized aligned fibers may be the next step following axon regeneration, in
order to maintain spinal cord architecture through the matrix.

72

Axon tracts above and below the transection have differing levels of
degradation. Wallerian degradation is a process that occurs following neurotrophic
support being removed from axon somas. If the baseline level of neurotrophic support
is removed from the neuron, it may undergo programmed cell death. If this occurs, the
myelin begins to degrade and fragment releasing neurite inhibitory debris. Axon tracts
that are no longer associated with a cell body also undergo this degradation, albeit on a
faster timeline. As this was a complete transection model of SCI, all neurons coursing
through the T8-T10 spinal cord were axotomized. One would expect all axon tracts to
have undergone devastating degradation 3 months post injury. While we subsequently
observe that in fact all tracts had undergone degradation, we were able to see very
distinct differences in amount of degradation suffered by each tract. This is an
interesting discovery, as this could prove some axon tracts are hardier then others
following significant injury. As the spinal cord is composed of both efferent and
afferent neurons, it is essential to consider where the cell body is relative to its white
matter tract. For example, the dorsal column gracile fasciculus has cell bodies caudal to
the lesion. Understandably, the gracile fasciculus caudal to the lesion appears to be very
well preserved, whereas the gracile fasciculus rostral to the lesion has undergone
complete degeneration. Not all tracts exhibit such predictable behavior, for example,
the rubrospinal tract exhibits similar degradation both rostral and caudal to the
transection. This is particularly applicable in the short term, where rescuing an axon
tract and having it reconnect to the distal end of the implant has yet to be accomplished.
By understanding which tracts maintain their structure and exhibit greater potential for
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regeneration, we can direct our efforts one tract at a time, which is something that
researchers are only beginning to explore.
It is important to remember that while axons receive the most attention from
researchers, vascular support is equally important. Following a spinal cord injury,
hemorrhage and inflammation occur. While inflammation has often been made out to
be a villain in spinal cord injury (Hirschberg et al., 1994; Blight, 1985), there is
evidence that they may also be integral to neural regeneration (Lu and Richardson,
1991; Perry and Brown, 1992). Due to the loss of vasculature, angiogenesis occurs in
response to the localized tissue hypoxia. Our experiments have resulted in the
formation of blood vessels in great numbers throughout our implants. We believe this is
because the endothelial cells are able to quickly migrate throughout the extent of the
matrix by following the aligned fibers. It is controversial whether angiogenesis is
beneficial or detrimental (Zhang and Guth, 1997; Wamil et al., 1998; Han et al., 2010),
however the point is irrelevant if new tissue is going to exist at the original site of
injury. The formation of new blood vessels in our implants is a step forward in the
creation of a permissible environment for axons to occupy in place of the fluid filled
cyst.
While we have shown great promise with the use of these electrospun implants,
there are issues that need to be addressed. In order to maintain proper orientation of
axon tracts throughout the implant, there must be no disruption of fiber alignment
anywhere in the implant. When the electrospinning process takes place, these matrices
that are created are handled frequently in order to perfect the shape, as well as to cut the
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matrix into an appropriate length for implantation. Much of the mechanical damage can
be prevented with experience and awareness; however there may also be modifications
that can be made within the implant engineering.

Chapter 4
Improving the bridge

Introduction
Spinal cord injuries have shown increasing promise with the use of
combinatorial strategies. An issue that all researchers dealing with contusion/cavitation
type spinal cord injuries is endpoint formation of a fluid filled cyst. Axons require
substrates to grow on, and thus a bridging material is required. In our lab, we use PDS
as our substrate to create a bridge for axons to grow. Using airgap electrospinning, we
are able to create a bridge that matches the shape of the spinal cord, while providing
highly aligned fibers that have been shown to direct neurite outgrowth. This
electrospun matrix can be enhanced with growth factors encapsulated within alginate
microspheres, as well as other bioactive compounds that are beneficial to regenerating
axons. Previously, the use of such bridges had shown a promising future, as axons,
cells, and vascular supply were found within the implant. Areas of cell infiltration from
the dorsal and ventral aspect of the implant seemed to create a segment of the implant
where axons could not traverse. Additionally, it was seen that fiber alignment played a
critical role in allowing cells to infiltrate deep into the implant. In an effort to enhance
the electrospun implant, we devised a method to provide an electrospun coating using
an alternate copolymer PGLA to direct cell infiltration from only the rostral and caudal
aspect, while preventing cell infiltration from the dorsal or ventral aspect. This
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copolymer had great success in preventing fibroblastic infiltration into the implant in
peripheral nervous system (Telemeco et al., 2005). Figure 4.1 shows an implant within
muscle tissue, with fibroblasts forming a capsule around PGLA copolymers. There is
no fibroblastic infiltration into the core of the implant.

Animals who receive

complete transectional spinal cord injuries exhibit total paralysis of hind limbs. This
demonstrates that the transection was in fact complete. In the weeks following injury,
BBB scores typically rise if any regeneration is occurring. In this experiment we
experienced little to no functional recovery as measured by the BBB scores (results not
shown). Animals in this experiment were examined for axon regeneration,
cellularization and vascular supply throughout the implants at 3 or 5 weeks post surgery.
Following tissue collection, immunolabeling of Neurofilament Heavy within these
animals showed that these axons were actually diverging away from the implants due to
the presence of a mesenchymal scar. As the goal of this experiment was to further
facilitate the axonal regeneration through our implant, this was an unfortunate turn of
events. Regardless, while axons were unable to get into our implants, cells and vascular
supply had no trouble entering the implant. In this chapter we attempt to understand to
a greater degree monofilament interactions post implantation, hypothesize explanations
for axon divergence, and document the creation of a vascular supply.

Results
Animals showed little to no signs of regeneration up to 5 weeks survival time.
Upon dissecting the spinal cords from the bony canals, it was evident that massive scar
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tissue was present. A previous experiment utilizing the same injury model resulting in
enhanced functional recovery displayed spinal cords that were very well integrated with
the implants. The spinal cords in this experiment were adhered to the lamina on many
occasions, with several spinal cords unable to be removed in one continuous piece.
Gross examination revealed what appeared to be the presence of blood vessels on the
surface of the implant, which was later confirmed at both the LM and EM levels.

Monofilaments:
Monofilaments were present in the implant as expected, however the number of
fibers was tremendously scarce compared to expectations. Since these animals had only
survived up to 5 weeks post surgery, it was of particular interest to see so little
monofilaments present in the implant itself. Large gaps in the implants were
immediately visible, with spaces between cells and ECM. These gaps could represent a
rate of degradation that was previously underestimated, but it is more likely an artifact
created during tissue processing for EM. Further evidence is shown in figure 4.2, which
appears to be a preserved cast of what the implant looked like prior to processing.
While it is uncertain exactly how this preservation took place, monofilaments can be
seen within perfectly round spaces, in a distribution resembling that of the SEM taken
when first designing the implant.
Also evident in these sections was the presence of macrophages engulfing
monofilament debris. Figure 4.7A is an example of endothelial cells wrapping around
monofilaments, however this image also depicts an area of the implant where
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macrophages are present and clearing out degrading monofilaments.

Axons:
Smi31 (Covance) was used to visualize Neurofilament H, a marker for mature
axons. In figure 4.3, axons fluorescing in red can be seen diverging away from the
electrospun fibers on the right. This shows that neuroregeneration taking place, as any
axons shown curving away from the implant has done so as a result of neurite growth
cones meeting a neuroinhibitory substance and redirecting the subsequent elongation of
the axon. This was a common occurrence to all animals. Cross sections taken through
the implant further revealed the absence of any axons in the implant.
To understand why these axons could not penetrate into the implant, we used
immunostaining to gain insight into what cell population was responsible for this
inhibition. Generally, a glial scar is often the component of neurite inhibition that repels
axons from the injury site. To combat this, our electrospun implants contained chABC,
which should have reduced the inhibitory activity of the compound CSPG that is
released from the astrocytes making up the glial scar. Further proof that the glial scar
was not responsible for this neuroinhibition was shown when we used a GFAP antibody
to show no astrocytes present in the scar tissue immediately surrounding the implant
(Figure 4.4A). However, by counterstaining with DAPI, we demonstrated that the
tissue surrounding the implant displayed massive cellularization (Figure 4.4C). Thus the
glial scar does not comprise the area responsible for neuroinhibition. Figure 4.5 is a
20x image of the scar tissue using a fibronectin (sigma) antibody. It appears as if
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fibronectin (a marker for fibroblasts) exists within this scar tissue, suggesting that this
scar is of mesenchymal origin.

Vascular supply
Despite the lack of axons growing through the implant, the PGLA capsule had
no discernible effect on vascular entry. Figure 4.6 shows RBCs throughout the extent of
the implant at 5 weeks post injury. These indicate in principle, the existence of
capillaries and a vascular supply. Cells are clearly seen throughout all matrices
implanted in animals regardless of PGLA capsule.
The evolution of a functional blood vessel within the matrix can clearly be seen
at differing levels of formation. Figure 4.7 shows blood vessels at varying stages of
formation and functionality. In 4.7A, an endothelial cell has wrapped the
monofilament, which occupies the entire lumen. This blood vessel is not functional as
the endothelial sprouting has likely not formed a loop for blood to flow. In 4.7B, the
monofilament within the lumen of the endothelial cell is not occupying the entire area.
This may be due to degradation of the monofilament. In 4.7C two monofilaments are
seen within a single lumen. This may be a case where monofilaments are spun in a
clump of fibers, such that a single endothelial cell could wrap two fibers simultaneously.
In 4.7D, the appearance of a RBC signifies a functional blood vessel. The
monofilament is seen within the lumen yet again, however is much smaller than the
lumen. In 4.7E, multiple monofilaments are seen within the lumen, but even more
relevant is the multiple RBCs that are present in the lumen. Quite a bit of blood flow is
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coursing through this blood vessel considering the lumen diameter. Finally 4.7F is
similar to 4.7E, however the tissue surrounding the endothelial cells are dramatically
different. Looking closely at 4.7F, there appears to be another area where a cast of the
monofilaments can be seen. Fibers with this type of distribution may have made up the
entire empty space seen in this image prior to processing.
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Figure 4.1. PLGA copolymer prevents fibroblastic infiltration when implanted
intramuscularly. This image depicts the use of a PGLA copolymer in a dermal
implant. The PGLA copolymer coating surrounded the core of the implant; fibroblasts
were unable to penetrate this PGLA copolymer and instead formed a fibrotic capsule.
FC = fibroblastic capsule, CC = core of the implant, M = endogenous muscle. Scale bar
= 5 um. (Adapted from Telemeco et al, 2005)
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Figure 4.2. Preservation of monofilaments through processing. An image through
the implant taken at 40x. This animal was given a complete transection and allowed to
survive 3 weeks post surgery. Large spaces within the implant were found which were
not present upon gross examination during dissection. This demonstrates a level of
artifact previously undocumented. The tissue processing required for EM greatly
degrades many of the monofilaments. Preserved within this image is a cast of what
appears to be the packing density of the monofilaments prior to tissue processing. It
more closely reflects what is expected of our matrices when spun. Scale bar = 20 um.
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Figure 4.3. Axons at the tissue implant interface. Regenerating axons are seen in
this image longitudinally at the spinal cord – implant interface. Post surgery, all axons
are transected and would be visualized longitudinally. All axons seen in cross section
are thus actively attempting to extend through the implant but unable to for unknown
reasons. Axons were immunolabeled for Neurofilament heavy chain. Scale bar = 20
um.
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Figure 4.4. Scar tissue at the tissue-implant-interface. The field of view in these
three images is identical. The arrow denotes the edge of our implant, where aligned
electrospun fibers can be seen. The left side represents spinal cord and scar tissue. (A)
This image was immunostained for GFAP astrocytic marker and visualized with an
FITC conjugated secondary antibody. Astrocytes are clearly seen in an extremely
condensed manner on the left. A gap of scar tissue remains separated from the
astrocytes and implant. (B) This is a phase image showing the aligned fibers of the
implant. (C) This is the same section with DAPI applied. Cells are seen in the space
between astrocytes and implant. Scale bar = 40 um.
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Figure 4.5. Fibroblasts at the tissue-implant-interface. This image was taken at 20x
at the border of electrospun implant and spinal cord. The image contains scar tissue on
the right and the aligned fibers on the left. This scar tissue may be responsible for the
axon divergence. The section was immunolabeled against fibronectin, which is
produced in fibroblasts. Fibronectin can be seen in the scar tissue as well as in the edge
of the implant, demonstrating the likelihood that this scar is not derived from cells
native to the CNS. Scale bar = 40 um.
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Figure 4.6. RBCs in the implant. Our implants show convincing evidence for
vascularization. This image was taken at 4x of the electrospun matrix 3 weeks post
injury. The aligned fibers can be seen in (A), with what appear to be tubes within.
Utilizing the intrinsic glutathion peroxidase activity of RBCs, DAB+Peroxide was used
to visualize RBC. These RBCs (Brown) display tremendous linearity and can be seen
within the lumen of these blood vessels throughout the implant. Scale bar = 200 um.

93

94

Figure 4.7. Generation of a functional blood supply within the implant.
Endothelial cells wrap their cell bodies around these monofilaments and are able to
grow long distances. The blood vessels become functional when these vessels sprout
off the monofilament and connect with other endothelial cells to form loops. In (A), a
monofilament occupies the entire lumen of an endothelial cell. The lumen is formed as
the monofilaments degrade (B). Multiple monofilaments may be utilized to form larger
blood vessels (C). When these endothelial cells undergo anastomosis, they become
functional blood vessels. This process does not require a monofilament to have fully
degraded as seen in images (D), (E) and (F). RBCs and monofilaments are present in
the lumen of these endothelial cells simultaneously. Scale bar = 20 um.
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Discussion
The use of combinatorial strategies addresses many obstacles facing SCI today.
No current therapy exists that can address all obstacles simultaneously. Furthermore,
differences in spinal cord injury models are not easily overlooked. The design of these
matrices was to fill a physical gap created by a fluid filled cyst, the endpoint for
contusional SCI. By switching to a transection model, we breach the meninges and
allow massive infiltration of cell types that do not normally exist within the CNS. This
is a problem that we must overcome if we are to use the complete transection model.
The hypothesized use of a PGLA capsule was one such attempt at keeping fibroblasts
from entering the implant. In contrast to expectations, in this experiment it did not
create a fibrotic capsule limited to the implant. It is convincing that the underlying
mechanism explaining the images of axons repelled prior to reaching our implant are in
fact due to a mesenchymal scar created by fibroblasts. A possible explanation for this
may be that the PGLA capsule caused greater irritation within the system, and thus
increased fibroblast attraction. The PGLA degradation may have decreased the pH and
affected fibroblastic attraction as well. Another possible explanation is increased
inflammation due to surgical damage. The surgical procedure, specifically, the amount
of tissue damage sustained during the surgery is a variable that is difficult to quantify.
This damage compounds the existing individual variability between rats used as test
subjects. Due to the fact that this experiment was performed by a less experienced
surgeon, it is plausible that this fibroblastic infiltration will reduce as the surgeon gains
experience. Regardless, the transection model should be performed in a manner as to
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leave the dura mater as unharmed as possible.
In principle, increased activated microglia and proliferation of macrophages
should come hand in hand with the induction of a greater inflammatory response.
While inflammation is a necessary step in wound healing, many of these inflammatory
cells may also release factors such as Fibroblastic Growth Factor (Tidball, 1995),
enhancing proliferation and migration of fibroblasts to the wound site.
While there is no image provided in this dissertation, many sections were
immunolabeled with iba-1, ionizing calcium binding adaptor molecule 1, which is
specifically expressed in activated macrophages and microglia. The experimental
animals showed a great deal of microglia activation and proliferation up to 5-6 mm
away from the site of injury, which may suggest that the cord was irritated or stretched
during surgery. Future experiments should continue to monitor microglial activation
and proliferation away from the site of injury, perhaps this may be used as an indicator
for surgical success beyond the generic loss of motor function.
The future usage of this PGLA coating is highly unlikely as previous
experiments without the use of PGLA have shown axon penetration into the implant.
The idea of creating a barrier to prevent unwanted cell infiltration is still relevant. Cell
type repulsion may also be used to ensure fibroblasts do not enter the implant. It has
been shown that astrocytes and non CNS cell types do not intermix harmoniously
(Behzadian et al., 1995; Wilby et al., 1999). By seeding the implant with astrocytes
prior to implantation, we may very well remove unwanted cell populations from
entering.
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Cell proliferation is evident soon after implantation and is dependent on
alignment of the monofilaments. Having areas where the electrospun fibers are
unaligned may compromise the continuity of any axon that enters the implant. Cells
were unable to enter in areas of non alignment. Despite these areas that lacked cells,
most implants contained a density of cells far greater than cord parenchyma. It was
observed that endothelial cells wrap around monofilaments to form functional blood
vessels. Endothelial cells prefer to grow on substrates, and it is likely that having
monofilaments of all different sizes facilitate endothelial cell proliferation and blood
supply formation. While many vessels contain degrading monofilaments within their
lumen, most do not. From this histological viewpoint, it is impossible to tell if at one
time they had monofilaments, because monofilaments appear to degrade at different
time points. Therefore, it is unknown to what extent endothelial cells prefer the use of
a monofilament. The appearance of a vascular network this quickly in the injury
timeline may be beneficial for clearing of debris and nutrient delivery. However, since
the blood spinal cord barrier has yet to be established, this also provides a direct route
for additional inflammatory, immune and fibroblastic cells to gain entry to the injury
site. While the establishment of a blood supply is essential in the grand scheme of
restoring complete function in the injured spinal cord, evidence has shown angiogenesis
can be both harmful and beneficial for spinal cord injuries. As pioneering blood vessels
have the capacity to influence axonal guidance (Rosenstein and Krum, 2004; Zhang et
al., 2009), the ability to entice endothelial cells to grow along the length of the implant
could prove beneficial. However, until we are able to document robust axon growth
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simultaneous with the establishment of vasculature, we can not confirm this suspicion.

Chapter 5
Future Modifications of Electrospun Spinal Cord Implants

Spinal cord injuries directly impact over 250,000 individuals nationwide,
diminishing quality of life considerably. Those who suffer from spinal cord injuries
suffer from a myriad of problems, including but not limited to paralysis, loss of
sensation, loss of bladder and bowel control, and loss of control over the sex organs.
The pathology of spinal cord injuries creates a complex problem that to date has had
little success in treating. Trauma to the spinal cord in both human and animal models
results in necrosis in and around the site of injury. Over weeks to months, a fluid filled
cyst often forms as an endpoint to the process. This cyst represents a physical
impediment to axon and functional recovery. Inhibitory molecules are present
throughout the cord following injury. Neurons who have undergone cell death are
unable to upkeep their myelinated axons, which begin to degrade. This myelin debris is
inhibitory to regenerating axons. In addition, inhibitory compounds are also released by
reactive astrocytes in the area. A combinatorial strategy addressing multiple obstacles
at once appears to offer potential for a meaningful functional outcome. Our lab utilized
a novel approach in electrospinning a 3-d matrix and adding trophic as well as
enzymatic support. Our electrospun matrices were able to be spun in proportion to the
rat spinal cord, with its fibers aligned longitudinally and capable of directing axon
growth. Additionally, we were able to supplement these electrospun matrices with
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alginate beads containing viable neurotrophic growth factors and other compounds
eliciting neuroprotective or neuroregenerative effects.
The electrospun matrices demonstrated were tested with a battery of in vitro
tests until finally placed into animals. Implants were placed into rats who received
complete transections of their spinal cords at the T8-T10 level. Rats given implants
showed an increase in the quality of their hind limb movements. This exciting
revelation led to an attempt to correlate the increased movements to the histology. The
primary focuses were to elucidate the monofilament integration into the ECM and host
tissue, the presence of axons in the matrix, the axon tract preservation above and below
the level of the injury, and how our implant affected vascular supply. What we
discovered was that our PDS monofilaments interacted seamlessly with the host tissues
and instigated a cellularity complete through the injury site. This proved to be a crucial
success for one of the primary purposes of the implant, to create a substrate that could
fill a cavity in a spinal cord injury. Indeed, axons could be found throughout the extent
of the implant. Loss of spinal cord architecture was observed, as well as a considerably
decreased number of axons when compared to an uninjured spinal cord. Above and
below the level of the lesion, axon tracts appear to have degraded at differential rates.
This is significant due to the fact that little is known about the hardiness of specific
axon tracts following injury. Generally, it appears that myelinated axons attached to the
somas undergo far less myelin degradation, whereas detached myelinated axons are
greatly degraded. Some axon tracts appear to show little regenerative capacity
regardless of distance from soma. All in all, more experiments need to be done
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assessing individual axon tracts in relation to their distance from the spinal cord
transection. Beyond axons, we also discovered that cellular infiltration readily
penetrated into the pores between the electrospun fibers, and ECM was laid down right
up to the fibers. Even more encouraging is the fact that certain cells appear to use these
monofilaments for structural support. Endothelial cells were found to wrap these
monofilaments throughout our implants. Further evidence demonstrated red blood cells
found in cross section through the lumen of these endothelial cells, as well as lines of
RBC's found in longitudinal sections of the implant. The restoration of vascular supply
supports the cellularization and potential for axon growth.
This experiment demonstrated the vast potential of these electrospun matrices.
Not only were these electrospun matrices viable bridges for axons to grow on, but they
also appeared to aid ingrowth of endothelial cells in reestablishing a functional vascular
supply. As expected, these bridges were anti-pyrogenic and anti-antigenic.
As a result of the previous experiment showing such promising results, we
perceived a novel method to enhance these matrices. A problem with the first implant
was the potential for cells foreign to the CNS to enter the bridge and disrupt axonal
growth. We hypothesized that fibroblasts that could enter the graft from the dorsal or
ventral aspect would repel and perturb the growth of axons through the area of
infiltration. We electrospun a PGLA coat over the PDS matrix to prevent fibroblastic
infiltration. These PGLA capsules were also notable for being anti-pyrogenic and were
used successfully in the PNS. These novel implants were utilized in vivo, with the
expectation that axons able to enter the implant would now have no roadblocks
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preventing linear growth to the opposing side. Unfortunately, few axons were able to
enter the implant. There were many ideas for this misstep. Clearly the only engineering
factor that changed was the addition of the PGLA capsule. This PGLA capsule may
elicit a different response in an injury to the CNS then an injury to the PNS. If the
PGLA were responsible for the additional inflammation, it would explain the
fibroblastic capsule surrounding the implant. This may not be the answer, as concurrent
to the design of the new implant; the laboratory lost the neurosurgeon responsible for
the surgeries performed in the past. Replacing this neurosurgeon was no simple task,
and the loss of his expertise on performing spinal cord transections may have resulted in
animals receiving excess trauma to the spinal cord and meninges. This excess trauma to
the area may have increased inflammation to the area of implantation, which would
have increased fibroblastic infiltration to the area. We believe fibroblasts are the main
villain in this experiment. Ultimately, the laboratory will return to the model of implant
that has shown previous success in the past, and eliminate the PGLA capsule. This will
allow us to discern which variable is responsible for the increased fibroblastic
infiltration. While axons were unable to enter the matrix, this did not stop the implant
from showing abundant cellularity within 3 weeks of implantation. Compared to the 12
week survival time of the first generation of implant, at 3 weeks, far less ECM has been
laid down. Large gaps were prevalent throughout these matrices, and monofilaments
were difficult to identify. This is confusing as the monofilaments should be
omnipresent within the matrix. Evidence could be seen demonstrating the original
orientation of fibers within the matrix; however these fibers are lost through the rest of
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the cross sections. This may show that the EM process itself may degrade our
monofilaments, preventing us from successfully seeing them at the LM level. While
monofilaments may be degraded in vivo or following tissue processing, there is no
denying the vascular network that has been formed. 3 weeks post injury; there is an
abundance of vascular support being generated. As seen in the previous figure, there
are blood vessels of all different stages of development present. This is a fascinating
method for creating functional vasculature.
While this experiment with second generation PGLA coated PDS capsules did
not offer functional recovery or axons in the implant, the future remains bright. In
subsequent experiments, we plan to remove this PGLA coat and return to the model that
was successful. We are currently investigating methods to cellularize these electrospun
fibers, so that we may fortify them with astrocytes or schwann cells. Additionally, we
are also investigating methods to utilize growth factor gradients to direct axons across
the bridge with lower and lower concentrations, so that these axons will have no
stimulus within the bridge. Future experiments will analyze the axon tract degradation
rates and survivability in the days to weeks following the transection. Hardier axon
tracts may exhibit greater potential for regeneration, and if this is the case, then specific
growth factors would be needed in gradient or non gradient form throughout the
implant. If axons are able to course the implant and reach the other side, neurotrophic
factors must be released from the peripheral targets to coax those axons off. Exercise
rehabilitation is an excellent subsequent step, as exercise rehab has been shown to
increase release of BDNF and other growth factors. Additionally, exercise rehab may
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help in maintaining motor end plates, muscle tone, and weight control in future rats.
Finally, as we continue to investigate spinal cord injuries and utilize the complete
transection model of injury, our surgical process will become further and further refined
to the point where we will have a surgeon that is able to minimally affect the spinal cord
and tissues, creating a much less traumatic injury. It has been shown that sealing the
dura mater following surgery improves functional outcome.
There is hope in the future that we will have the tools and experience necessary
to perform a perfectly reproducible surgery that exhibits minimal trauma to the animal
and preserves the dura. The implant will have neurotrophic support targeting different
axon tracts in gradients that promote axon growth through the implants to the other end.
Trophic factors and guidance molecules stemming from exercise rehabilitation induced
neurotrophin release would facilitate axonal exit from the implant. The future looks
promising in the field of spinal cord injury.
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